Continuous Glucose Monitoring (CGM) Devices—a deep-dive on How Athletics Trend Redefines Digital Health [Business]
Athletes have exhibited immense traction in tracking glucose levels continuously. So much so that CGM technology has become sought-after to see how their training and food influence their blood glucose levels all the time. The advanced CGM devices enable consumers to make diet and training decisions to help boost their performance. There have been instances in the past of the National Football League (NFL) using CGM devices. Some well-established brands, such as Abbott (Libre Sense), Supersapiens and Nutrisense, have furthered their penetration to tap into the global market.
Sports and fitness enthusiasts have joined the bandwagon to enhance their fitness performance. It is worth mentioning that CGM is less invasive and some devices can be connected to Bluetooth, making the product highly popular among amateur and professional athletes. Grand View Research is gearing up to add OTC CGM devices used in non-diabetes applications and their impact on the blood glucose monitoring device market in its repository. The final report, coupled with the database, will emphasize the following dynamics:
• Opportunities for CGM manufacturers and analytics service providers
• Trends that can influence the prospect and application of CGM devices in fitness enthusiasts and diabetic patients.
• Insights on Medicare and Medicaid coverage.
• CGMs pricing among athletes and patients.
Get your copy or request a free sample of the report “A Study On New Vertical Growth Opportunities for Continuous Glucose Monitoring Devices,” compiled and published by Grand View Research.
Vertical Growth Opportunities for CGM Devices Report Scope
Patient Demographics
- Total Population
- People with diabetes
- People with undiagnosed diabetes
- Deaths attributable to diabetes
- Sport enthusiasts
- Number of athletes
Pricing
Pricing for CGMs in diabetic patients vs Athletes
Reimbursement Differences
Coverage for Medicare and Medicaid
Regions
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Get more insights from our in-depth market intelligence report “Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Receivers), By End-use (Hospitals, Home Care), By Connectivity, By Region, And Segment Forecasts, 2023 - 2030”
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
Diabetes Type 1 and Type 2—a Study on Country-wise Disease Demographics [Business]
The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks.
Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:
• Decision-making process and customer buying pattern.
• Reimbursement landscape and diabetes-related expenditure per person.
• Treatment options and related costs across countries.
• Comparative prevalence of diabetes.
Get your copy or request a free sample of the report “Disease Demographics for Diabetes Type 1 and Type 2, 2023,” compiled and published by Grand View Research.
Disease Demographics for Diabetes Type 1 and Type 2 Report Scope
Patient Demographics
- Total Population
- People with diabetes
- People with undiagnosed diabetes
- Deaths attributable to diabetes
Treatment Options
- Type 1 Diabetes
- Insulin
- Diet
- Blood glucose monitoring
- Type 2 Diabetes
- Oral Medications
- Diet
- Exercise
- Blood glucose monitoring
- Insulin
Treatment Cost Per Patient
- Total diabetes-related health expenditure, USD Million
- Diabetes-related health expenditure per person, USD
Quality of Life
- Disability-adjusted life years (DALYs)
Comorbidity Analysis
- Diabetic foot ulcer
- Cardiovascular disease (CVD)
- Diabetic retinopathy
- Diabetic neuropathy
- Diabetic nephropathy
Reimbursement Differences
- Coverage for Medicare and Medicaid
- Type 1 Diabetes
- Type 2 Diabetes
Regions
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Related Reports:
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
Viral Vector—Perusal on Adeno-associated Viruses (AAVs) in Gene Therapy Development [Business]
The medical industry expects viral vectors to grow in prominence in transferring genetic material into the genetic composition of cells. Adeno-associated Viruses (AAVs) have become sought-after in gene therapy as they can deliver genetic material to cells and do not cause disease. Predominantly, adenovirus, retrovirus, herpes simplex virus and lentivirus, among others, are used to transfer genetic material into cells’ genetic composition. Technological advancements in manufacturing AAV vectors have encouraged stakeholders to boost their portfolios. An uptick in research activities in viral vector-based cell and gene therapies has redefined the global landscape. For instance, in 2020, over 100 gene-therapy products were observed in clinical trials.
Pharma companies, investors, venture capitalists and other stakeholders will possibly explore the growth potential in viral vectors. The final report, along with the database, will deep-dive into the following industry dynamics:
• AAV vectors approved by governing bodies, including FDA and the European Medicines Agency. Zolgensma was approved by EMA and FDA in 2020 and 2019, respectively, while Luxturna received the green signal from FDA in 2017 and EMA in 2018.
• Insights on potential challenges for AAV manufacturers, such as cost, degradation during supply chain and preparation of stable viral vectors.
• Influence of the COVID-19 pandemic on vaccine development.
• Acquisitions of biotech startups
Get your copy or request a free sample of the report “Viral Vector Development - Focus on Adeno-associated Virus, 2018 – 2021,” compiled and published by Grand View Research.
Viral Vector Report Scope
Market Lineage
- % Captured by AAV within Viral Vectors
- Understanding of the parent market and ancillary industriesPlasmid DNA Contract Manufacturing
- Cell & Gene Therapy Clinical Trials Market
Industry Dynamics
- Viral Vector based gene therapy development
- AAV Development workflow
- Pipeline for AAV
- Capitalist funding in the industry
- Development Process
Deep dive Analysis
- Understanding of AAV v/s Lentiviral v/s other viral vectors
- Cost of manufacturing (based on batch size) - a case study
- Case study on setting up a development plant
Competition Analysis in CDMOs
- Companies with products in clinical trials
- Various bioreactors used for development
- Strategic initiatives undertaken in the last 5 years
Observation and Recommendations
This section will summarize the entire study and provide analyst insights with regards to key methods of development, technological advancements, and competitive profiling
Get more insights from our in-depth market intelligence report “Viral Vector Market Size, Share & Trends Analysis Report By Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), By Application, By End-user, By Region, And Segment Forecasts, 2023 – 2030”
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
Xenotransplantation—Study on Animal-to-Human Organ Transplantation [Business]
Patients dying on the waiting list hoping to get lifesaving organ transplants have strengthened the significance of cells and tissue transplantation. The studies on xenotransplantation have become pronounced with an emphasis on bone-related conditions, wound healing/burn care, dental, breast reconstruction and adenocarcinoma.
Frontiers of transplanting nonhuman organs or tissues into human recipients have put the spotlight on pigs. While fish skins have been successfully used for burn wounds, pigs have become sought-after in xenotransplantation studies. Some of the analyses have pegged the success rate for the pig to primate transplantation from 60% to 80%.
The report, along with the database, highlights the following dynamics:
• Potential applications of xenotransplantation.
• Genetically engineered pigs.
• Insights on research activities.
• Mega trends and growth opportunities redefining the global landscape.
Get your copy or request for a free sample of the report “Xenotransplantation and Its Potentials - Outlook on Ongoing Studies,” compiled and published by Grand View Research.
Xenotransplantation Report Scope
Research Studies
- Total Studies
- Success rates
- Disease areas
- Alternative applications
Conditions covered
- Wound healing/burn care
- Bone related conditions
- Dental
- Adenocarcinoma
- Breast reconstruction
Animals covered
- Pigs
- Fish
Comorbidity Analysis
- Side effects
- Success rates
Related Reports:
- Transplantation Market Size, Share & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2023 – 2030
- Wearable Artificial Organs Market Size, Share & Trends Analysis Report By Product (Kidney, Cochlear Implant, Exoskeleton, Vision Bionics, Brain Bionics), By Technology (Mechanical, Electronic), By Region, And Segment Forecasts, 2020 - 2027
About Us
Grand View Research, Inc. is a market research and consulting comp make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
Healthcare Outsourcing Industry—an Exposition of Top 10 Trends Reshaping the Global Dynamics [Business]
The rising applications of CROs, including augmented reality (AR), virtual reality (VR) and mixed reality (MR) have fueled the demand for healthcare outsourcing. The adoption of ML and AI has become pronounced in the wake of increasing scrutiny to adhere to regulatory compliance of healthcare products. For instance, AI can propel transparency with accurate results and enhance the efficiency and pace of product development. Since AI is less prone to human error, it enables better quality control to bolster decision-making.
An uptick in the number of decentralized clinical trials (DCTs) in 2021 leveraged forward-looking companies to penetrate the pharmaceutical industry. The number of DCTs was forecast to be pegged at 1300 trials by 2022-end.
The report will offer a bird’s eye view of qualitative development/s in the healthcare outsourcing landscape. The final report, coupled with the database, will offer insights into the following dynamics:
- Capacity expansion in niche markets; decoupling of service offerings; rise in safety assessment; and extended reality.
- Diversifying geographical footprints and mergers & acquisitions. In 2021, over 132 M&As were completed.
- The expanding footprint of personalized medication, genomics and biosimilars.
- IoT implementation and innovations.
Get your copy or request for a free sample of the report “Healthcare Outsourcing Industry – Analysis of Top 10 Trends,” compiled and published by Grand View Research.
Healthcare Outsourcing Industry Report Scope
|
Attribute |
Details |
|
Divestiture/Consolidation Activities |
|
|
Innovation |
|
|
Globalization |
|
|
Virtual Augmentation |
|
|
Service Portfolio Modification |
|
|
Capacity Expansion in Niche Markets |
|
Related Reports:
- Digital Health Market Size, Share & Trends Analysis Report By Technology (Healthcare Analytics, mHealth, Tele-healthcare, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2023 – 2030
- Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CVD), By End User (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2022 – 2030
About Us
Grand View Research, Inc. is a market research and consulting comp make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
Why Investing in the Electric Passenger Cars Industry is a Smart ESG Choice [Business]
Sustainability for mobility has prompted electric passenger cars industry players to prioritize environmental, social and governance (ESG) goals. Heightened demand for decarbonization and the need to bring sustainability perspectives into management have encouraged incumbent companies to foster their ESG strategies. Climate change response has become global, suggesting an emphasis on the environment throughout the value chain, including design, manufacturing, procurement, logistics and disposal.
Premium automotive brands have shifted their attention toward sustainability to improve customer trust, boost compliance, enhance investor confidence and bolster brand reputation. A transition towards electric brands comes against the backdrop of soaring inflation, supply chain disruption and higher interest rates. In an unexpected turn of events, the exorbitant price of lithium propelled production costs for EVs; Russia’s Ukraine invasion and surging energy prices have had an overarching influence on the global economy.
AB Volvo Redefines Scope 3 Emissions for Consumer-Driven Culture
Although 2022 was a year full of challenges for automakers, 2023 has promised to provide compelling opportunities to navigate ESG strategies. Predominantly, AB Volvo has taken a giant stride to combat climate change—contemplating minimizing scope 1 & scope 2 emissions by 50% by 2030. The Swedish multinational company aims to cut scope 3 emissions by 40% per vehicle Km from trucks and buses, respectively, and 30% from construction equipment by 2030. The automotive giant has upped its efforts to do away with conventional energy sources and adopt renewable sources. During 2022, there was a 32% reduction in tailpipe emissions per average vehicle (vis-à-vis 2018 baseline). The company is gearing up to develop renewable electricity for vehicle charging, alluding strong demand for bio-based materials.
Is your business one of participants to the Electric Passenger Cars Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices
Toyota Prioritizes Social Sustainability
Workplace safety, reduction in accidents and diversity are shaping the future of transportation as automakers inject funds into state-of-the-art products and services. With the demand for personal vehicles soaring, sustainable development has become invaluable to creating a prosperous society. To illustrate, Toyota Australia has powered 7,883 solar panels to its Altona Toyota Parts Centre, which produces 2.5MW. In FY 2022, the auto giant incentivized Toyota and Lexus customers to recycle 1,954 hybrid batteries to foster battery recycling. The automotive brand donated USD 3.4 million to community partners working in sustainability, education, traffic safety, social justice and the environment. Moreover, Toyota Kirloskar Motor, a Joint Venture between Toyota and Kirloskar, trained around 43,673 supplier members to boost environment and social performance.
Mercedes-Benz Ups Governance Stewardship
Decision-making bodies have exhibited concerted efforts toward transparency, ethics & compliance, robust corporate governance and board diversity to bolster their ESG performance. In 2021, Mercedes-Benz made a resource conservation policy to minimize the energy consumption per vehicle for cars by 43% and 25% for Vans by 2030. The Luxury vehicle company has introduced supply chain policies to allow purchasers to track material data with the help of blockchain technology. The automotive brand has propelled its diversity and equity portfolio to keep up with the Sustainable Development Goals, including gender equality and reduced inequalities. As of December 2021, Mercedes-Benz had 22.5% of women in senior management positions, while the Board of Management had 3 women and 5 men.
The competitive scenario indicates that forward-looking companies could focus on organic and inorganic strategies to expand their global footprint. In doing so, well-established players will likely invest in technological advancements, innovations, product offerings, collaborations, R&D activities and mergers & acquisitions. The electric passenger cars market size stood at USD 120.81 billion in 2020 and will witness a healthy CAGR of 32.5% between 2021 and 2028. The outlook suggests that the sustainability and success of automakers could depend upon sound corporate governance, bullish environmental targets and social sustainability.
About Astra – ESG Solutions by Grand View Research
Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.
Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.
For more ESG Thematic reports, please visit Astra ESG Solutions, powered by Grand View Research
Veterinarians—a Deep Dive into Number of Animal Doctors Based on Countries [Business]
Veterinary services have witnessed an unprecedented spike on the back of surging demand for quality pet care. Some factors, such as an uptick in pet adoption, the prevalence of chronic diseases and growing pet insurance services, have spurred the market penetration of animal doctors. For instance, Europe has around 309,144 veterinarians (39 FVE member countries), according to a European Federations of Veterinarians survey. Clinical practice (contributing to 58% of all respondents’ occupations) is the most prevalent employment sector.
The database lists the U.S. with the maximum number of veterinarians. The U.S. houses over 45,857 animal health organizations. The final report, along with the database, will peruse the following dynamics:
- Insights on leading countries, including U.S., France, Germany, Belgium, Spain, Netherlands and Malaysia.
- Number of veterinarians based on the primary area of specialization, occupation, or core specialty, including but not limited to companion animal exclusive, mixed animal, food animal exclusive and companion animal predominant.
- Growth opportunities and trend assessment.
- Qualitative and quantitative analysis.
Get your copy or request for a free sample of the report “Estimated Number of Veterinarians by Key Countries, and Year, 2017 – 2021.”
Estimated Number of Veterinarians by Key Countries - Report Scope
|
Scope |
Details |
|
Actual estimates/Historical data |
2017 - 2021 |
|
Quantitative units |
Number of Veterinarians from 2017 to 2021 |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Country Scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Singapore; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
By Practice Type |
Practice type includes private clinic practice and public & corporate employment. These segments are further subdivided into sub-segments, and data available are only for the key market: U.S. |
|
By Area of Work for Veterinarians |
Quantitative data on the number of veterinarians who work with companion animals, food-producing animals, equines, and aquaculture and data availability for EU countries |
|
Companion Animals/Food producing animals/Equine/Aquaculture |
Numbers are based on the survey of veterinarians and vets are not exclusive of companion animals |
Related Reports:
- U.S. Veterinarians Market Size, Share & Trends Analysis Report By Sector (Public, Private (Food Animal Exclusive, Companion Animal Exclusive, Mixed Animal, Equine, Others), Academics), And Segment Forecasts, 2022 - 2030
- Veterinary Services Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion), By Region (North America, Latin America, APAC), And Segment Forecasts, 2021 - 2028
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
Ion Channels in Drug Discovery—a Granular Report Addressing Pharmaceutical Companies Target Market [Business]
Prevalence of Parkinson’s disease, autoimmune dysfunction and cardiac arrhythmias has brought a paradigm shift in their treatment through ion channel modulators. The rising footprint of drug discovery has furthered the penetration of ion channels. Drug discovery, with the support of ion channel targeted mechanism of action, accounts for around 12% to 15% of the research studies. Moreover, in 2022, there were 19% of marketed drugs, further validating ion channels as the third largest group of target proteins in drug discovery.
Ion channel-based drug development will be pronounced following the completion of human genome sequencing in April 2022. Pharmaceutical companies could unlock growth potentials with an infusion of funds into R&D activities and outsourcing.
• Assessment of ligand-gated ion channels and voltage-gated channels.
• Insights on preclinical development, target identification & screening, target validation & functional informatics and lead identification & candidate optimization.
• Deliberate upon potassium-, calcium- and sodium –channels.
• Competitive landscape and inputs on the ion channel drug discovery outsourcing services
Get your copy or request for a free sample of the report “Ion Channels in Drug Discovery, 2023 Report,” compiled and published by Grand View Research.
Ion Channels in Drug Discovery Report Scope
|
Attribute |
Details |
|
Key Driver Analysis |
|
|
Key challenges |
|
|
Categorization of Ion Channels |
|
|
Regional Analysis |
Market performance across the 5 regions |
Analyzing the Sustainability of the Bioplastics Industry [Business]
Bioplastics have come on the horizon to boost sustainability amidst plunging reserves of fossil fuels. Plastics based on renewable resources have fostered sustainability as environmental concerns surge with the growing prevalence of non-biodegradable plastics in landfills. Industry players are prioritizing environmental, social and governance impacts of their operations and exhibiting efforts to minimize their negative effects in these facets. A soaring number of companies are exhorting their commitment to sustainability through ESG reports. Predominantly, in December 2021, the United Nations recommended bioplastics as a sustainable alternative to non-biodegradable conventional polymers.
Plastic manufacturers are expected to count on recommended products from FAO, including fishing gear, mulch films, polymer-coated fertilizers, plant support twines, tree guards and shelters and pesticide-impregnated fruit protection bags. In essence, biodegradable mulch films can be incorporated into the soil after harvest, suggesting its influence in boosting sustainability. The global push for a circular economy has put the spotlight on bioplastic manufacturers.
Key Companies in this theme
• TEIJIN LIMITED
• TORAY INDUSTRIES, INC.
• Toyota Tsusho Corporation
• Avantium
• Solvay
Bolstering Carbon Neutrality to Foster Environmental Pillar
Business entities are responding to trends, including technological advancements and lack of resources, with investments in sustainability. Biodegradable solutions have become invaluable with the unprecedented impact of climate change on global warming. According to the Intergovernmental Panel on Climate Change (IPCC) report, emissions are required to be minimized by a minimum of 43% by 2030 (vis-à-vis 2019 levels) and at least 60% by 2035 to keep global warming within the 1.5°C limit. The UNFCCC Climate Champions assert that the net-zero transition would need USD 125 trillion by 2050 in climate investments.
Companies, such as Toray have upped their efforts to be carbon neutral by 2050. The company is committed to achieving the target by minimizing GHG in its business operations and launching carbon recycling technologies. The Japan-based company is minimizing product weight to reduce fuel consumption and explore renewable energies. Energy consumption from renewable energy sources at Toray Industries was pegged at 1.2 million gigajoules in FY 2020. The green transition is poised to usher in bullish ESG strategies in the near term.
Emphasis on Mental Health to Underscore Social Commitment
With the circular economy bringing tailwinds across business verticals, employee safety & well-being, diversity and a human-centered approach have garnered immense traction. For instance, Solvay has created a flexible working framework in its operations globally—over 7,500 employees worked in hybrid models in 2022. The company also created a November 2022 Pulse survey on well-being and inclusion.
The repercussions of the COVID-19 pandemic prompted industry leaders to prioritize mental health management and breakdown silos. The company infers it trained around 1,150 employees in well-being webinars and workshops. It also introduced the Employee Assistance Program to provide free psychological support, life coaching, mindfulness and well-being advice for all employees and members of their households. In July 2022, amidst high inflation, the Belgium-based company announced a €9.5 million (roughly USD 10.4 million) infusion for the affected employees in high-inflation countries not protected by national schemes. These financial incentives are slated to drive innovation, performance and better risk management.
Is your business one of participants to the Bioplastics Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices
Sound Corporate Governance to Stay Ahead of the Curve
Forward-looking companies have exhibited a commitment to high ethical standards, transparency and fairness to bolster brand positioning and meet social and environmental goals. Business management and decision-makers are banking on sound corporate governance to take their bioplastic initiatives to new heights. To illustrate, Toyota Tsusho is gearing up to underpin its speed and repertoire of decision-making through the establishment of the chief compliance officer (CCO), chief financial officer (CFO), chief strategy officer (CSO) and chief digital & technology officer (CDTO) positions.
The board of directors has become instrumental to enhance the corporate value and supervise the execution of duties by directors. So much so that four are outside directors at Toyota Tsusho, while the non-executive director serves as the Board chairman. In a bid to bolster corporate governance, its company-wide meeting system leverages directors and executive officers to assess countermeasures to deal with issues impacting the company.
The competitive landscape suggests that well-established and emerging players could inject funds into organic and inorganic strategies to tap into the global market. Companies will continue prioritizing environmental pillars, social justice, equity, diversity and inclusion to propel their ESG goals. In January 2022, Avantium reportedly built the first bioplastic plant in Dutch Delfzijl. Establishing the commercial plant would produce 5 kilotons of FDCA (raw material for PEF) per year. These buoyant initiatives are a testament to the fact that Grand View Research valued the global bioplastics market size at USD 10.2 billion in 2021 and could depict a 17.1% CAGR from 2022 through 2030.
About Astra – ESG Solutions by Grand View Research
Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. – a global market research publishing & management consulting firm.
Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.
For more ESG Thematic reports, please visit Astra ESG Solutions, powered by Grand View Research
U.S. Wheelchair Market—a Deep-dive of Top Brands & Consumer Demographics [Business]
An uptick in disability rates across the U.S. has fueled the need for wheelchairs. The Census report in 2020 asserted that around 5.5 million people used wheelchairs. Besides, the U.S. is listed among the top three countries (disability rates). Disabled athletes have sought mobility devices for ease of use and self-functioning. Self-propelled wheelchairs have gained ground with soaring demand for mobility and lightweight across tennis, basketball and marathons. Furthermore, attendant-propelled wheelchairs have received the impetus in airports and hospitals.
Wheelchair manufacturers have bolstered their product lines to keep up with the consumer preference. The U.S.-specific report will peruse the demand analysis with the data sets on the prevalence/rise of disability, education, household income, race, gender and ethnicity. The final report, coupled with the database, will offer a granular assessment of the following dynamics:
• Top selling/demanded products and different categories of wheelchairs.
• Comparative analysis with respect to, including but not limited to, product material, applicability, braking systems, size & dimensions and cushioning systems.
• Consumer perception and insights on why certain brands have the edge over competitors.
• Inputs on electric and manual wheelchairs
Get your copy or request a free sample of the report “U.S. Wheelchair Market - Analysis of Top Brands,” compiled and published by Grand View Research.
U.S. Wheelchair Market Analysis by Top Brands Report Scope
Consumer Demographics
- Prevalence of disability in the U.S., by age
- Prevalence of disability in the U.S., by gender
- Prevalence of disability in people by Hispanic/Latino origin and age group in the U.S.,
- Annual household income
- Prevalence of Disability in the U.S., by Education
Wheelchair Adoption Rate
- Wheelchair users in the U.S., by Age
- Wheelchair users in the U.S., by Gender
- Wheelchair users in the U.S., by Location
- Wheelchair users in the U.S., by Race
- Wheelchair users in the U.S., by Ethnicity
- Wheelchair users in the U.S., by Income
- Wheelchair users in the U.S., by Education
Top Brands
- Top brands for Electric Wheelchair
- Top brands for Manual Wheelchair
- Top brands for Transport Wheelchair
- Top brands for Lightweight Wheelchair
- Top brands for Innovative Wheelchair
Comparative Brand Analysis
- Brand Analysis on the following parameters:
- Material
- Size & Dimensions
- Braking Systems
- Cushioning system
- Application
- Others
Pricing Analysis
Brand wise Pricing
Get more insights from our in-depth market intelligence report, “North America Wheelchair Market Size, Share & Trends Analysis Report By Product (Manual, Electric), By Category Type (Adult, Pediatric), By Application, By Region, And Segment Forecasts, 2023 – 2030.”
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
